Research on the Motivation of Financial Fraud in Chinese Pharmaceutical Industry-Taking Kangmei Pharmaceutical as an Example

Abstract

With the advancement of living standards and the continuous rise in demand for healthcare security, the pharmaceutical industry is poised for significant development. However, recent years have witnessed a concerning trend of financial misconduct among several publicly listed pharmaceutical companies in China. This unethical behavior has not only cast a shadow over the Chinese pharmaceutical market but also reverberated throughout the broader capital market. Consequently, an in-depth examination of the motivation of financial fraud within China's pharmaceutical sector holds profound importance.